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Positive Regulation of Myogenic bHLH Factors
and Skeletal Muscle Development
by the Cell Surface Receptor CDO
E proteins are ubiquitously expressed and function as
“generic” heterodimerization partners for tissue-spe-
cific bHLH factors whose expression is spatially and
temporally restricted and that regulate determination
and differentiation of cells within specific lineages (Mas-
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and Developmental Biology
Mount Sinai School of Medicine
New York, New York 10029 sari andMurre, 2000). However, E proteins also produce
homodimers, which are required for B cell-specific tran-
scription and development (Massari and Murre, 2000;
Zhuang et al., 1994). The mechanisms by which dimer-Summary
ization of Eproteins is regulated are notwell understood.
Several observations indicate thatmyogenesis is pos-Skeletal myogenesis is controlled by bHLH transcrip-
tion factors of the MyoD family that, along with MEF-2 itively regulated by cell-cell contact between muscle
precursors. Such interactions are important for myo-factors, comprise a positive feedback network that
maintains themyogenic transcriptional program. Cell- genic determination anddifferentiation of explanted em-
bryonic mesodermal cells (Cossu et al., 1995; Gurdoncell contact between muscle precursors promotes
myogenesis, but little is knownof theunderlyingmech- et al., 1993). Likewise, differentiationof certainmyogenic
cell lines is dependent on cell aggregation (Redfield etanisms. CDO, an Ig superfamily member, is a compo-
nent of a cell surface receptor complex found at sites al., 1997; Skerjanc et al., 1994), and high cell density
promotes differentiation of cultured myoblast cell lines.of cell-cell contact that positively regulates myogen-
esis in vitro. We report here that mice lacking CDO Although withdrawal of serum is most commonly used
to induce differentiation of such cells, the effects of cell-display delayed skeletal muscle development. Addi-
tionally, satellite cells from these mice differentiate cell contact may well be more physiologically relevant.
Several specific cadherins, Ig superfamilymembers, anddefectively in vitro. CDO functions to activate myo-
genic bHLH factors via enhanced heterodimer forma- other cell surface glycoproteins have been implicated
in these phenomena (Dickson et al., 1990; George-tion, most likely by inducing hyperphosphorylation of
E proteins. The Cdo gene is, in turn, a target of MyoD. Weinstein et al., 1997; Goichberg and Geiger, 1998; Holt
et al., 1994; Zeschnigk et al., 1995). However, themecha-The promyogenic effect of cell-cell contact is there-
fore linked to the activity of myogenic bHLH factors. nisms bywhich these proteins stimulatemyogenesis are
largely unknown. In particular, it is not known whetherFurthermore, themyogenic positive feedback network
extends from the cell surface to the nucleus. engagement of such proteins via cell-cell contact has
a role in regulating the transcription factors of the core
positive feedback network.Introduction
CDO is an orphan cell surface receptor of the Ig super-
family that is expressed on muscle precursor cells andIn vertebrates, skeletal muscles of the trunk and limbs
arise from the somites. Muscle precursor cells are de- developing muscles, as well as on other cell types, dur-
ingmouse embryogenesis (Kang et al., 1997, 1998; Muli-rived from the dorsal epithelial portion of the maturing
somite, the dermomyotome, and will subsequently form eri et al., 2000). CDO is a component of a complex found
at sites of cell-cell contact that includes the related Igthe myotome, a set of differentiated muscle cells that
underlies the dermomyotome and will give rise to the superfamily member, BOC, and the promyogenic cell
adhesion molecules, N- and M-cadherin (Kang et al.,back musculature or migrate to form more distal mus-
cles. Specification and differentiation of cells in the skel- 2002, 2003). CDO positively regulates differentiation of
myoblast cell lines, as assessed by both morphologicaletalmuscle lineage are controlledby themyogenic basic
helix-loop-helix (bHLH) transcription factors MyoD, Myf-5, and biochemical criteria (Kang et al., 1998, 2002, 2003).
Furthermore, interaction between CDO and promyo-myogenin, and MRF4 (Arnold and Braun, 2000). After
extrinsic signals induce expression of the specification genic cadherins is required for CDO function (Kang et
factors Myf-5 and MyoD in muscle precursor cells, the al., 2003). Based on its activity in vitro and its functional
myogenic bHLH factors cooperate with each other and interaction with cadherins, CDO is a strong candidate
with the MEF-2 family of transcription factors to auto- to mediate some of the effects of cell-cell contact that
and cross-activate their own expression, resulting in are important in myogenesis. Interestingly, transforma-
a “core” positive feedback network that amplifies and tion of C2C12 myoblasts with oncogenic Ras results
maintains the intrinsic transcriptional program in this in downregulation of MyoD and Cdo expression and
cell lineage (Molkentin and Olson, 1996; Yun and Wold, inhibition of differentiation (Kang et al., 1998; Lassar et
1996). The myogenic bHLH factors must heterodimerize al., 1989). Forced reexpression of either MyoD or CDO
with another class of bHLH factors, the E proteins (e.g., in C2C12/Ras cells induces endogenousMyoD andCdo
the E2A gene products, E12 and E47), in order to bind and acquisition of the ability to differentiate in the pres-
to their target sequences and transactivatemuscle-spe- ence of Ras (Kang et al., 1998; Lassar et al., 1989). These
cific genes (Lassar et al., 1991; Massari and Murre, 2000). and additional data have led to the hypothesis that,
following cell-cell contact, CDO signals to posttransla-
tionally activate MyoD, thereby helping to amplify and*Correspondence: robert.krauss@mssm.edu
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Figure 1. Delayed Expression of Myf-5, MyoD, and myogenin in Cdo/ Embryos
Whole-mount RNA in situ hybridization for the indicated probes on Cdo/ or Cdo/ (top) and Cdo/ (bottom) embryos of identical somite
numbers at the indicated embryonic stages. /, Cdo/ or Cdo/, which were phenotypically indistinguishable; /, Cdo/.
Lateral views of whole embryos are shown in (A), (E), (I), and (M), thoracic regions in (D), (G), (H), (L), and (P), hindlimb and posterior somites
in (B), (C), (F), and (O), forelimb buds in (J) and (N), and branchial arch and anterior somite regions in (K). Myf-5 expression was reduced
in / embryos in all somites at E10.5 (E) and is absent in the caudal half of E9.5 embryos (H) and the caudal third of E10.5 embryos (F,
arrowhead; H). The ventral expression domain of Myf-5 is reduced in interlimb somites at E11.5 (G; wild-type domain indicated by brackets).
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maintain the myogenic bHLH-MEF-2 network and, con- in Cdo/ mice, but unlike the wild-type expression pat-
tern, they are undetectable in the caudal half of E9.5sequently, the intrinsic myogenic transcriptional pro-
gram. We also posit that the Cdo gene is, in turn, itself embryos and the caudal third of E10.5 embryos (Figures
1F and 1H). In addition, the ventral expansion of Myf-5a target of MyoD and/or other myogenic factors, creat-
ing a positive feedback loop between the cell surface expression was delayed in both E10.5 and E11.5 em-
bryos, resulting in reduced size of the expression do-and the nucleus.
This hypothesis leads to several predictions, among main (Figures 1G and 1H).
MyoD expression is first induced in the ventrolateralthem that Cdo/ mice would have defective skeletal
muscle development and that each “half” of the pre- domain of interlimb somites at E9.75 and later expands
throughout the myotome. By E10.5, expression ofMyoDdicted feedback loop be demonstrable in the absence
of an intrinsic myogenic transcriptional program. We can also be detected in the forelimb buds, mandibular
branchial arches, and hypoglossal chord (Chen et al.,report here that Cdo/mice show delayed myogenesis,
and primary myoblasts from such mice differentiate de- 2001). The induction of expression in the somite, and
expansion of the expression domain, wasmildly delayedfectively in culture. Furthermore, CDO signals to activate
myogenic bHLH factors in 10T1/2 cells via enhanced at E10.5 (Figures 1I and 1L). However, MyoD expres-
sion was indistinguishable from wild-type by E11.5 (Fig-heterodimer formation, most likely by inducing hyper-
phosphorylation of E proteins. Finally, Cdo expression ure 1L and Supplemental Figure S1 at http://www.
developmentalcell.com/cgi/content/full/7/6/843/DC1/).is induced in 10T1/2 cells by MyoD. These results indi-
cate that the promyogenic effect of cell-cell contact is MyoD transcripts were also reduced in muscle precur-
sors of the forelimb buds and the hypoglossal chord,linked to MyoD activity via posttranslational modifica-
tion of E proteins and that the myogenic positive feed- as well as branchial arch muscle at E10.5 (Figures 1J
and 1K).back network extends to the cell surface.
Myogenin transcripts are first seen in myotomes at
E8.5 and continue to be expressed in all myotomes and
areas of muscle cell differentiation throughout develop-Results
ment (Sassoon et al., 1989). Cdo/ mice showed de-
layed myogenin induction and expression at all stagesCdo/ Mice Display Delayed Skeletal Myogenesis
To assess the role of CDO in skeletal muscle develop- analyzed (Figures 1M–1P). E9.5 Cdo/ embryos dis-
played a dramatic delay in induction of myogenin inment, we studied mice with a targeted mutation of the
Cdo gene (Cole and Krauss, 2003). 52 Cdo/ embryos myotomes, and the expression domain ofmyogeninwas
reduced ventrally in all somites through E11.5 (Figureswere analyzed during critical stages of muscle develop-
ment;Cdo/mice expressmarkers of muscle specifica- 1N and 1P). Expression of myogenin in fore- and hind-
limbs, hypoglossal chord, and branchial archeswas alsotion and differentiation, but expression is reduced and
delayed in onset when compared with heterozygous or delayed in Cdo/ animals (Figures 1M–1O). As alter-
ations in Pax1 expression and sclerotome developmentwild-type littermates. This phenotypewasobservedwith
100% penetrance, but somewhat variable expressivity. were not observed in Cdo/ embryos, CDO does not
play a major role in somitogenesis; rather, it regulatesWhole-mount RNA in situ hybridization was used to
assess expression of Myf-5, MyoD, and myogenin in myogenic induction and differentiation. In addition, al-
though myotome development was delayed in Cdo/Cdo/ and Cdo/ embryos of equivalent somite num-
bers collected at embryonic day 9.5 (E9.5), E10.5, and mice, the recovery of a normal expression pattern of
MyoD by E11.5 indicates that CDO hasmore of an effectE11.5. Pax1 was examined as a control because it is
expressed in the sclerotomal compartment of the somite on the induction and/or maintenance of expression of
Myf-5 andmyogenin than onmyotome formation per se.(Deutsch et al., 1988), whereas Cdo expression is re-
stricted to dermomyotomes and myotomes (Mulieri et To further examine the muscle phenotype of Cdo/
mice, sections of embryos from E9.5 to E14.5 were ana-al., 2000). Cdo/ embryos showed a wild-type pattern
of Pax1 expression (Figures 1A–1D). In contrast, expres- lyzed for expression ofmusclemarkers by immunohisto-
chemistry. Consistent with the RNA in situ analyses, insion of the myogenic bHLH factors in somites, and in
somite- and cranial paraxial mesoderm-derived pre- developing myotomes of 23-somite embryos, the num-
ber of cells expressing the determination markers des-musclemasses,was delayed inCdo/embryos (Figures
1E–1P).Myf-5 is initially expressedwithin the dorsomed- min and myogenin was reduced in Cdo/ embryos rela-
tive to Cdo/ embryos, as was the level of expressionial region of the most rostral somites at E8.0. Its expres-
sion expands caudally into newly formed somites and within positive cells (Figures 2A–2C). A comparable situ-
ation was observed in developing limbs (Figures 2E andventrally as they mature to form the dermomyotome and
myotome (Ott et al., 1991).Myf-5 transcripts are present 2F) and diaphragm (data not shown) at E13.5. Mutant
MyoD transcripts were reduced throughout the embryo at E10.5 (I), within forelimb myocytes (J, arrowhead), and in the hypoglossal chord
(K, arrowhead), mandibular arch muscle precursors (K, asterisk), and interlimb somites (L). By E11.5, the MyoD expression domain (bracket)
in / embryos was identical to wild-type (L, also see Supplemental Figure S1). myogenin expression was reduced throughout E9.5 to E11.5
(M–P), including in the hypoglossal chord (M, arrowhead), branchial arch (M, asterisk), forelimb (N, arrowhead) at E10.5, and hindlimb (O,
arrowhead) at E11.5. Thoracic region somites showed a delay in myogenin expression at E9.5 (P) and reduction in the size of the expression
domain (bracket) at E11.5 (P).
Scale bar shown in (A) equals 200 m for (A), (E), (I), and (M); all other scale bars equal 100 m.
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Figure 2. Delayed Skeletal Muscle Development in Mice that Lack CDO
(A–D) Transverse serial sections through 23-somite embryos were stained with antibodies to desmin (A, C, and D) or myogenin (B) and sections
through identical somites compared. (A) Cervical level somites; (B) forelimb level somites; (C) the most caudal somites displaying myotomes;
(D) heart. In (A) and (B), twodifferentCdo/ embryos are presented to show the rangeof expressivity of the phenotype./,Cdo/;/,Cdo/.
(E) Transverse sections from size-matched / and / littermates at E13.5 were aligned to the growth plate and plane of the scapula (S)
and stained with an antibody to desmin. Red arrow, premuscle mass of the trapezius; black arrow, premuscle mass of the serratus anterior;
NT, neural tube.
(F) Adjacent sections to those shown in (E) stained with an antibody to MHC (fast).
(G) Transverse sections through the developing tongues of / and / littermates at E14.5 stained with an antibody to desmin.
(H) Cross-sections through E18.5 hindlimbs of / and / littermates were stained with hematoxylin and eosin (H&E). TA, tibialis anterior;
TP, tibialis posterior; EDL, extensor digitorum longus; T, tibia; F, fibula.
(I) Cross-sections through the tibialis anterior of adult mice stained with H&E.
Scale bars equal 10 m for (A)–(D) and 100 m for (E), (F), (H), and (I).
embryos developed all premuscle masses of the limb, 2H). Additionally, cross-sections through the tibialis an-
terior of surviving adult mice indicated that Cdo/ ani-but they were smaller and less well condensed than
those of size-matched wild-type littermates. Further- mals ultimately produced normally sizedmyofibers (Fig-
ure 2I). It is concluded that CDO is not essential formore, though they expressed desmin, the signal was
much less intense within individual cells and in the mus- skeletal muscle development but is required for the pro-
cess to occur in a timely and efficient fashion. This phe-cle groups as a whole. In addition, Cdo/ embryos only
weakly expressed the differentiation marker, muscle- notype is reminiscent of the delayed myogenesis seen
in mice lacking either Myf-5 or MyoD (Braun et al., 1992;specific myosin heavy chain (MHC). Analogous results
were obtained with antibodies against myogenin and Kablar et al., 1997; Rudnicki et al., 1992).
We also analyzed primary myoblasts (satellite cells)troponin T (data not shown). Similar to what was ob-
served in somites and limbs, the developing tongues of isolated from the limbs of postpartum day 21 (P21)
Cdo/ and Cdo/ animals. As expected, CDO proteinE14.5 Cdo/ embryos displayed large desmin-positive
myofibers, while Cdo/ embryos had fewer and irregu- levels were high in Cdo/ cells but absent in Cdo/
cells (Figure 3A). Cdo/ and Cdo/ myoblasts hadlarly patternedmyofibers that stained less intensely (Fig-
ure 2G). In contrast to these observations, expression equivalent amounts of the determination factor, MyoD
(Figures 3A and 3B); in contrast, Cdo/ cells expressedof desmin in developing heart muscle, where Cdo is not
expressed (Mulieri et al., 2000), was unaffected inCdo/ less than half the amount of the differentiation factor,
myogenin, than that seen in wild-type cells (Figure 3A).embryos (Figure 2D).
Despite the defects in muscle development seen in Furthermore, whereas wild-type cells produced large
myotubes with many nuclei, mutant cells formed almostCdo/ embryos between E9.5 and E14.5, skeletal myo-
genesis recovered in Cdo/ animals. Sections through exclusively myocytes with fewmyotubes observed (Fig-
ure 3C). The Cdo/ cells did, however, produce MHCE18.5 hindlimbs of homozygous mutants revealed proper
organization of all muscle groups, although they were (as assessed by immunostaining [Figure 3C] and immu-
noblotting [data not shown]). Consistent with the in vivoslightly smaller than those of Cdo/ animals (Figure
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Figure 3. Primary Myoblasts from Cdo/
Mice Display Defective Differentiation In Vitro
(A) Western blot analysis of CDO, MyoD, and
myogenin in primary myoblasts from Cdo/
and Cdo/ animals.
(B) Immunocytochemical analysis of MyoD
expression in primary myoblasts. Note that
virtually all cells express MyoD (green fluo-
rescence).
(C) Primary myoblasts of the indicated geno-
type were cultured in differentiation medium,
fixed, and stained with an antibody to MHC.
data, therefore, primary myoblasts that lack CDO dis- or CDO. However, these proteins displayed reduced
mobility on SDS-PAGE in CDO transfectants (Figure 4B),played a defective differentiation response in vitro.
These cells were infected with a retrovirus harboring a suggesting that E proteins might be the relevant recipi-
ents of CDO-initiated signals. The effects of CDO wereCdo cDNA and a puromycin resistance gene or, as a
control, a retrovirus lacking a cDNA. During selection of not due to massive overexpression, as the small amounts
of MyoD expression vector used in these transientCdo virus infectants, the Cdo/ cells underwent prema-
ture differentiation into spindle-shaped myocytes that assays had only a trace effect on endogenous CDO
levels, and the amount of CDO produced by transfectioncould not be propagated, and stable drug-resistant cells
did not express CDO (Supplemental Figure S2 and data of the CDO expression vector was only 2- to 3-fold
higher than that observed endogenously in primarymyo-not shown). As this retroviral expression vector does
not lead tomassive overexpression of CDO inmyoblasts blasts (Supplemental Figure S3).
MyoD contains a basic (B) region that binds DNA,or fibroblasts (Kang et al., 1998, and see below), we
believe that deregulated expression, rather than overex- an HLH domain that mediates dimer formation with E
proteins, an N-terminal transactivation domain, and ad-pression, of CDO is responsible for the precocious dif-
ferentiation observed. ditional transcriptional regulatory regions in its N and C
termini (Davis and Weintraub, 1992; Gerber et al., 1997;
Weintraub et al., 1991). The B region and the junctionPosttranslational Activation of MyoD by CDO
Our previous work led to the hypothesis that CDOmight (J) between the B and HLH regions are responsible for
the myogenic specificity of MyoD (Davis andWeintraub,signal to activate MyoD posttranslationally and that the
Cdo gene is a target of MyoD (Kang et al., 1998). To 1992). To identify the region of MyoD that confers CDO
responsiveness, we analyzed the effects of CDO on Eassess these possibilities, it was important to use a
cell type in which an intrinsic myogenic transcriptional proteins and on a set ofMyoDmutants, including chime-
ric proteins made between MyoD and E proteins (Figureprogram was not already established, so as to study
these processes independently and avoid high endoge- 4C). In addition to heterodimerizing with tissue-specific
bHLH proteins, E12 and E47 homodimerize to activatenous background. We therefore used 10T1/2 cells,
which express no MyoD and very low levels of CDO B cell-specific genes (Massari and Murre, 2000). Homo-
dimer activity can be monitored with a reporter drivenendogenously (Kang et al., 1998), but in which transient
and stable assays of MyoD activity are widely used. by the immunoglobulin E2,3,5 enhancer. Chimeras in
which the B or B plus J regions of E12 are replaced withExpression of CDO enhanced MyoD-dependent re-
porter activity driven by the muscle creatine kinase en- those of MyoD convert E12 into myogenic factors (E12-
MyoD(B) and E12-MyoD(BJ)) that activate muscle-spe-hancer or by four reiterated MyoD binding sites (4Rtk)
by 3- and 5-fold, respectively (Figure 4A). CDO did not cific reporters (Davis and Weintraub, 1992). A chimera
containing the MyoD bHLH segment fused to the trans-activate the reporter in the absence of MyoD, nor did
it enhance the activity of a MEF-2-dependent reporter activation domain of VP16 (NCMyoD-VP16) permits
assessment of the role of the MyoD N and C termini.construct (data not shown). Furthermore, CDO’s effect
on reporter activity occurred without any change in the Cotransfection of CDO repressed E12 and E47 activity
on the E2,3,5 reporter by 60% (Figure 4D). Interest-level of MyoD protein (Figure 4B). It is concluded that
a given amount ofMyoD ismore active in thepresence of ingly, CDO repressed the activity of the E12-MyoD(B)
and E12-MyoD(BJ) chimeras on the 4Rtk reporter tocotransfected CDO. Immunoblots of whole-cell extracts
revealed that the levels of endogenous E12 and E47, a similar extent (Figure 4D). Although these chimeras
contain the regions ofMyoD that confermyogenic speci-which migrate together predominantly as two bands
(Bradney et al., 2003; Lassar et al., 1991), were also ficity, they responded to CDO like E proteins; thus, the
B and J regions are not responsible for CDO’s ability tounchanged by transfection of 10T1/2 cells with MyoD
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Figure 4. The HLH Domain of MyoD Confers
Responsiveness to CDO
(A) 10T1/2 cells were transiently transfected
with the indicated plasmids and analyzed for
CAT reporter activity. Values are means  1
SEM from at least three experiments, each
performed in triplicate.
(B) Analysis of exogenousMyoD and endoge-
nous E12/47 protein expression in transient
transfectants similar to those in (A). The anti-
body to E12/47 recognizes allE2A gene prod-
ucts, which migrate together predominantly
as two bands. The asterisk indicates a reduc-
tion in mobility of E12/47 in CDO transfec-
tants. IP, immunoprecipitation; WB, Western
blot; WCE, whole-cell extract.
(C) Schematic structure of MyoD, E12, E47,
and chimeric proteins derived from them. The
reporter genes on which they were assayed
in (D) and (E) are shown on the right.
(D and E) Transient reporter assays with the
indicated plasmids were performed as in (A).
activate MyoD. In contrast, the activity of NCMyoD- with increasedamounts of transfectedMyoDexpression
vector, because high MyoD protein levels will drive di-VP16 was enhanced by CDO (Figure 4E). Because the
only functional portions of MyoD in NCMyoD-VP16 merization by mass action. While CDO strongly en-
hanced reporter activity driven by0.2gofMyoDvector,are the B, J, and HLH domains, we conclude that the
HLH region is the CDO-responsive region of MyoD, sug- it had little effect on activity driven by 1.0 g of vector
(Figure 5B). Furthermore, CDO responsiveness was re-gesting that CDO activates MyoD by enhancing its het-
erodimerization with E proteins. To test this notion, we stored to this high level of MyoD by cotransfection of
an equivalent level of E12 vector, a condition whereassessed the activity of CDO onMyoDE47 (Figure 4C),
a “forced dimer” in which MyoD and E47 are covalently competition between homo- and heterodimerization
should be regained (Figure 5B). Third, it should be possi-tethered via a flexible linker (Neuhold and Wold, 1993).
If dimerization is the process affected by CDO, CDO ble todeterminewhat type ofCDO-inducedmodification
present on E12/47 results in their altered mobility. Asshould have no effect on MyoDE47 activity; this is
what was observed (Figure 4E). A model consistent with seen with endogenous E12/47, E12 and E47 expressed
from cDNAs showed reduced mobility by SDS-PAGEthe data in Figure 4 is that CDO-initiated signals result
in modification of E12/47 such that the equilibrium of when coexpressed with CDO and treatment of extracts
with phosphatase resolved all bands to equivalent mo-their dimerization is shifted from the homodimeric state
toward the heterodimeric state, activating MyoD. bility (Figure 5C). Analysis of E47 by two-dimensional gel
electrophoresis revealed multiple species, suggesting
that it is highly phosphorylated even in the absence ofCDO Enhances Heterodimer Formation
exogenous CDO; upon coexpression of CDO, multiplebetween MyoD and E12/47
new species with reduced pI and increased apparentThismodel was tested in several ways. First, if E proteins
molecular weight were produced (Figure 5D). Phospha-are the recipients of the CDO-initiated signal, othermyo-
tase-treated samples displayed one major form of E47genic bHLH factors should also be activated in the tran-
in the presence or absence of CDO, indicating that allsient reporter assay, as they too require heterodimeriza-
these distinct species of E47, including those producedtion for activity. CDO enhanced both myogenin- and
by CDO expression, resulted from phosphorylation (Fig-Myf-5-dependent transactivation (Figure 5A). Second, if
ure 5D). Consistent with these findings, endogenousdimerization equilibria were affected by CDO, the ability
of CDO to enhance MyoD activity should be diminished E12/47 was hypophosphorylated in Cdo/ myoblasts
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Figure 5. CDO Induces Hyperphosphorylation of E Proteins and Enhances Heterodimer Formation between MyoD and E12/47
(A and B) Transient transfections of 10T1/2 cells were performed with the indicated plasmids as in Figure 4.
(C) CDO induces phosphorylation of E12 and E47. 10T1/2 cells were transfected as in Figure 4 with expression plasmids for E12 or E47,
MyoD, and plus or minus CDO as shown. Whole-cell extracts were treated or mock-treated with lambda protein phosphatase (-PPase) plus
or minus phosphatase inhibitors and subjected to SDS-PAGE followed by Western blotting with antibodies to E12/47 (E2A) or 9E10 to myc-
E47. WB, Western blot; WCE, whole-cell extract.
(D) Expression of CDO induces hyperphosphorylation of E47. 10T1/2 cells were transfected with plasmids bearing E47, MyoD, and plus or
minus CDO as indicated and prepared as in (C). Extracts were isoelectrically focused across a pH gradient of 3–6 followed by separation on
SDS-PAGE and Western blotting with 9E10 antibody to myc-tagged E47. The blots treated with phosphatase were exposed to film for less
time as the resolution to a single spot increased the signal intensity.
(E) Myoblasts lacking CDO have hypophosphorylated E12/47. Whole-cell extracts from myoblast cell lines derived from Cdo/ and Cdo/
mice were prepared as in (C) followed by Western blotting with antibodies to E12/47 (E2A) and phospho E2A pT355 (pT355). The asterisk
indicates reduction in mobility of E12/47 in wild-type myoblasts.
(F) CDO increases the amount of E12/47 that coimmunoprecipitates with MyoD. 10T1/2 cells were transfected as in Figure 4, and cell lysates
were immunoprecipitated with 9E10 to exogenous myc-MyoD and blotted with antibodies to either E12/47 (endogenously expressed) or myc-
MyoD. Transfection efficiencies between the minus and plus CDO conditions were equivalent and identical amounts of extract were analyzed.
IP, immunoprecipitation.
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Figure 6. MyoD Induces Cdo Expression
(A) Western blot analysis of CDO andmuscle-
specific proteins in 10T1/2 cell clones in-
fected with control (LSXN-1) or MyoD-ER-
expressing (MyoD-ER-2, -3) retroviruses.
Cells were cultured with or without 4HT.
(B) Northern blot analysis of 4HT-induced ex-
pression of Cdo and myogenin. Cells were
incubated with or without 4HT and cyclohexi-
mide (CHX; 50 g/ml) as shown for the indi-
cated times. The ethidium bromide-stained
gel is shown as a loading control.
compared with Cdo/ myoblasts, as indicated by both proof of a role in vertebrate skeletalmuscle development
increased mobility on SDS-PAGE and decreased con- for the cell surface proteins implicated in this phenome-
centration of E12/47 phosphorylated on threonine 355, non has been slow to emerge. We have studied CDO, an
a proline-directed kinase site known to be targeted by Ig superfamily member, and previous results indicated
the promyogenic kinase, ERK (Figure 5E; Nie et al., 2003; that CDO is a strong candidate to mediate some of the
Wu et al., 2000). Finally, it should be possible to observe promyogenic effects of cell-cell contact. CDO positively
an increase in the levels of E2A gene products that regulates differentiation of myoblast cell lines in vitro in
associate with MyoD in the presence of CDO. As pre- a fashion dependent on a functional association with
dicted, the amount of endogenous E12/47 that coimmu- cadherins (Kang et al., 1998, 2003). Furthermore, studies
noprecipitated with MyoD was enhanced by coexpres- on the ability of CDO and MyoD to reactivate the myo-
sion of CDO (Figure 5F). Taking the data in Figures 4 genic program in Ras oncoprotein-transformed C2C12
and 5 together, it is concluded that CDO stimulates cells revealed that CDO and MyoD might be involved in
myogenic bHLH activity by targeting E12/47 for hyper- a positive feedback loop (Kang et al., 1998). Here, we
phosphorylation, presumably resulting in enhanced het- demonstrate that mice lacking CDO display delayed
erodimerization, most likely at the expense of E pro- skeletal muscle development; that expression of CDO
tein homodimers. induces hyperphosphorylation of E proteins; that CDO
signals to activate MyoD posttranslationally via en-
MyoD Induces Cdo Expression hanced heterodimerization; and that the Cdo gene is
To test whether Cdo expression itself is a target of induced byMyoD. Taken together, these results indicate
MyoD, a conditionally active MyoD-estrogen receptor that the activation state of myogenic bHLH factors is
chimera (MyoD-ER) was employed. Expression of regulated by cell-cell contact and that CDO, a cell sur-
MyoD-ER in 10T1/2 cells confers 4-OH-tamoxifen (4HT)- face protein, is a component of an extended feedback
dependent myogenic differentiation (Hollenberg et al., loop with nuclear myogenic factors.
1993). Clonal derivatives of 10T1/2 cells that stably ex-
press MyoD-ER and matched vector controls were gen-
erated. Immunoblot analyses of these cell lines revealed CDO Positively Regulates Skeletal Muscle
that 4HT treatment of 10T1/2-MyoD-ER cells, but not Development In Mice
control cells, resulted in the induction of endogenous Skeletal muscle development is delayed in mice that
MyoD and MHC (Figure 6A). While the basal level of lack CDO; morphological, RNA in situ hybridization, and
CDO protein in the different cell lines was somewhat immunohistochemical analyses revealed that myogen-
variable, 4HT treatment led to a robust increase in CDO
esis initiated belatedly and remained inefficient inCdo/
protein levels in two independent MyoD-ER lines,
embryos at least through E14.5. This was observed in
whereas the control line showed no such response (Fig-
the earliest structures of themuscle compartment (myo-ure 6A). Northern blot analysis indicated that Cdo was
tomes) and in premuscle masses of various parts of theinduced by 4HT at the RNA level and that, in contrast
embryo. However, by E18.5 muscle development hadto myogenin, induction was blocked by cycloheximide
recovered, with Cdo/ animals having apparently nor-(Figure 6B). Therefore, new protein synthesis is required
mal muscle. This is similar, at least superficially, to micefor MyoD-ER to upregulate Cdo expression. Addition-
that lackMyoDorMyf-5 singly (Braun et al., 1992; Kablarally, Cdo mRNA levels continued to rise over a 2 day
et al., 1997; Rudnicki et al., 1992). These latter strainsperiod of treatment with 4HT. These results suggest that
of mice show delayed myogenesis that is specific to thefactors induced by MyoD are likely to be needed for
hypaxial and epaxial musculature, respectively (Kablarexpression of Cdo. However, MyoD directly activates
et al., 1997). In contrast, the defect in mice lacking CDOboth “early” and “late” genes during differentiation (Berg-
appears to be general for all somitic musculature. Thisstrom et al., 2002), so a direct role for MyoD in this
phenotype is consistent with the mechanism by whichresponse may also occur. In either case, it is clear that
CDO activates myogenic bHLH factors in vitro and withMyoD induces Cdo expression.
the likelihood that CDO activates multiple members of
this family.Discussion
While several cell-cell adhesion and related cell sur-
faceproteins havebeendemonstrated to promotemam-It has long been observed that cell-cell contact between
malian myogenesis in vitro (Dickson et al., 1990; Goich-muscle precursors promotes myogenesis, but the un-
derlyingmechanisms are obscure. Furthermore, genetic berg and Geiger, 1998; Redfield et al., 1997; Zeschnigk
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et al., 1995), there is little genetic evidence to clearly reduced in Cdo/ somites at this stage; and MyoD
mRNA is expressed subsequent to this stage (Braun etsupport an in vivo role for such molecules. For example,
al., 1992; Faerman et al., 1995).lack of N-cadherin,M-cadherin, or NCAM inmice results
Primary myoblasts from Cdo/ animals produce nor-in no reported defect in myogenesis (N-cadherin knock-
mal levels of MyoD but have hypophosphorylated E12/outmicedie prior tomuscle development, butmyoblasts
47 and significantly reduced levels of myogenin relativerendered null in culture are not defective) (Charlton et
to control cells. Consistent with this, Cdo mutant em-al., 1997; Cremer et al., 1994; Hollnagel et al., 2002; Radice
bryos show only mild delay ofMyoD expression, whereaset al., 1997). Therefore, of the molecules that have been
expression of myogenin is more dramatically affected.proposed to mediate the promyogenic effects of cell-
As myogenin is a target of MyoD and Myf-5 early incell contact, CDO is the first for which genetic evidence
myogenesis, the reduced levels of myogenin in Cdo/exists. While loss of, for example, one cadherin may
cells and embryos is consistent with a failure of Cdo/be compensated for by a related family member, CDO
myoblasts to fully activate MyoD and/or Myf-5 in vitroclearly plays a nonredundant role in myogenesis.
and in vivo. Interestingly, despite failing to express nor-
mal levels of myogenin,Cdo/myoblasts were not obvi-CDO Activates MyoD and MyoD Induces Cdo:
ously deficient in expression of the differentiationAn Extension of the Core Myogenic
marker, MHC. It has been reported that MyoD directlyPositive Feedback Loop
regulates several kinetically distinct subprograms ofCoexpression of CDO significantly enhances MyoD ac-
gene expression and that these subprograms weretivity in transient reporter assays. Numerous lines of
achieved in part bymodulation of transcription of certainevidence all point to amechanismbywhichCDO signals
genes by specific signal transduction pathways (Berg-to activate MyoD posttranslationally via enhanced het-
strom et al., 2002). CDO-mediated signals may similarlyerodimerization with E proteins, most likely at the ex-
regulate some, but not all, such subprograms.pense of E protein homodimers. Amodel consistent with
It seems unlikely, however, that enhanced heterodi-these data is that CDO initiates signals that result in
merization ofmyogenic bHLH factors will prove to be thehyperphosphorylation of E12/47 such that the equilib-
only mechanism by which CDO promotes myogenesis.rium of their dimerization is pushed toward the hetero-
Primary myoblasts that lack CDO fail to fuse into myo-dimeric state. Evidence for kinase pathways altering
tubes, and thismay arise from a combination of subopti-bHLH dimerization has recently been shown for Hand1
mal myogenic bHLH activity and additional defects in(Firulli et al., 2003). Phosphorylation of the Hand1 HLH
signaling events that are required for the morphologicaldomainbyPKCandPKA reduced its dimerization affinity
changes that accompany fusion. Although direct evi-with E12/47, thereby increasing its ability to homodimer-
dence for this possibility is lacking, overexpression ofize. CDO-mediated phosphorylation of E12/47 may
CDO in myoblast cell lines accelerates and enhancesmake their homodimerization electrostatically or steri-
elongation and alignment of differentiating cells and re-cally unfavorable. CDO is expressed during develop-
sults in larger myotubes with increased numbers of nu-ment in several different cell types that rely on divergent
clei (Kang et al., 1998).
tissue-specific bHLH factors (e.g., muscle, neural, and
Expression of theCdo gene itself is induced by activa-
dermal precursors) (Mulieri et al., 2000). The mechanism
tion of a stably expressed MyoD-ER chimera with 4HT.
described here is appealing because it enables CDO to
The induction was blocked by cycloheximide, indicating
signal to ubiquitous proteins (E12/47) yet drive tissue- a need for new protein synthesis in this process. It is not
specific gene expression in each lineage by stimulating clear whether MyoD actually binds directly to regulatory
heterodimer formation with the tissue-specific partner. elements in the Cdo gene, the induction is mediated
Our results are similar to those reported for the effects by other transcription factors induced by MyoD, or a
on MyoD and E47 of casein kinase II (CKII), which phos- combination of the two.
phorylates E47 in vitro (Johnson et al., 1996; Sloan et Taken together, these results demonstrate that each
al., 1996). Furthermore, one site (T355) targeted by CDO “half” of a CDO-MyoD feedback loop can be demon-
is known to be phosphorylatedbyERKs,whichplay both strated independently in fibroblasts, with CDO signaling
positive and negative roles in muscle cell differentiation to posttranslationally activate MyoD via enhanced het-
(Nie et al., 2003; Wu et al., 2000). Perhaps CKII, ERK, erodimerization and MyoD inducing Cdo expression
and/or other kinase(s) lie downstream of CDO in signal- (Figure 7). It is significant that these processes occur in
ing pathways that result in E protein phosphorylation 10T1/2 cells, in the absence of a pre-existing myogenic
and consequently influence dimerization partner choice. program. The ability of CDO to activateMyoD andMyoD
The delay in skeletal myogenesis seen in Cdo/ ani- to induce Cdo is therefore not dependent on additional
mals is consistent with regulation of myogenic bHLH muscle-specific factors or secondary to establishment
factor heterodimerization as a mechanism of action, in of the core myogenic positive feedback network that
that heterodimers would still be expected to form in the includes the myogenic bHLH andMEF-2 families. These
absence of CDO, but at lower efficiency. Most of our observations extend the myogenic positive feedback
studies in vitro have focused on MyoD, due to its preva- network to the cell surface. An “extended” positive feed-
lence in myoblast cell lines and the availability of MyoD back network provides an explanation for some of the
mutants and chimeras. However, the delay in myotome promyogenic role of cell contact between muscle pre-
formation seen in E9.5 Cdo/ embryos strongly sug- cursors, in that a cell surface receptor found at func-
gests that Myf-5 is also a target of CDO signals in vivo, tional sites of cell-cell contact is linked to the activity
because Myf-5 is required for timely development of of lineage-restricted transcription factors. The defect
displayed byCdo/mice indicates that this is importantmyotomes; expression of myogenin, a Myf-5 target, is
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Reporter Assays and Coimmunoprecipitation
C3H10T1/2 (10T1/2) cells (passage 11 to 20) were cultured as de-
scribed (Kang et al., 1998) and transfected with FuGene6 (Roche).
CDO and all bHLH constructs were expressed from the vector pBabe-
Puro, exceptNCMyoD-VP16 (pEMSV). Each plate received a total
of 10 g DNA (Figure 5B received 12 g) of the indicated plasmids,
including 0.5 g pCMV-lacZ to calculate transfection efficiency.
After transfection, cells were maintained in DMEM/10% FBS for
2 days and then transferred to DMEM/2% horse serum for 2 days.
CAT activity was equilibrated on the basis of -galactosidase (-gal)
activity and quantified on a Molecular Dynamics PhosphorImager.
For coimmunoprecipitations and immunoblotting, cells were
treated as above and harvested after 1 day in DMEM/2% horse
serum. The extracts were incubated with anti-c-Myc (9E10) conju-
gated agarose (Santa Cruz). E2A gene products were detected with
anti-E2A.E12 antibody (Santa Cruz). Precipitated MyoD was de-
tected with the 9E10 antibody.
Phosphatase Assays and 2-Dimensional Electrophoresis
Cells were transfected with either HA-MyoD and myc-E47 or myc-
MyoD and E12 vectors; pCMVlacZ; and pBabePuro or pBabePuro-
CDO. Half of each extract was prepared in lysis buffer supplemented
with phosphatase inhibitors. Extracts were treated with Lambda
Protein Phosphatase (New England Biolabs) for 1 hr at 30C. For
2-dimensional electrophoresis, phosphatase- andmock-treated ex-
tracts were TCA precipitated and passively rehydrated into pH 3–6
ReadyStrip IPG strips (BioRad). Isoelectric focusing was then per-
formed on a Protean IEF cell (BioRad) according to manufacturer’s
instructions. Samples were then separated on a 4%–15% gradient
SDS-PAGE gel. Electrophoresis and immunoblotting were per-
Figure 7. Model for Positive Feedback between CDO andMyogenic
formed as described above with 9E10, E2A.E12, or phospho E2A
bHLH Factors
pT355 (Bethyl Laboratories) as indicated.
CDO exists in a complex with BOC, cadherins, and -catenin at
sites of cell-cell contact (Kang et al., 2002, 2003); CDO signals to MyoD-ER and Nothern Blot Analysis
induces hyperphosphorylation of E proteins and shift the equilibrium The MDER-SN construct (Hollenberg et al., 1993) was transfected
of E protein dimerization to the heterodimeric state. Box: myogenic into φNX-E and viral supernatants used to infect 10T1/2 cells. The
bHLH factor (M)/E protein (E) heterodimers are part of a core feed- cultures were selected in G418, and clones that differentiated well
back network with MEF2, maintaining their own expression and in medium containing 4HT (1 M) were analyzed. Clones with empty
driving muscle-specific gene expression. Cdo (and probably Boc vector, LXSN, were used as control. Northern blot analysis was
[Kang et al., 2002]) is also a target, creating a positive feedback loop. performed as previously described (Kang et al., 1998).
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